Xiaoyun Dong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaoyun Dong has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- David Wei Zhang
State Key Lab of ASIC & Systems, Fudan University, Shanghai 201203, China
2 shared publications - Hui Wang
Department of Chemistry, Fudan University, 2205 Songhu Road, Shanghai 200438, China
2 shared publications - Ru-Lei Zhang
Department of Chemistry, Fudan University, 2205 Songhu Road, Shanghai 200438, China
2 shared publications - Shi-Xian Gan
Department of Chemistry, Fudan University, 2205 Songhu Road, Shanghai 200438, China
2 shared publications - Congying Guo
Department of Chemistry, Fudan University, 2205 Songhu Road, Shanghai 200438, China
1 shared publication - Gang Zhao
School of Materials Science and Engineering
1 shared publication
Latest Publications
- 17 July 2026
- Published by Elsevier in Chinese Chemical Letters
- Vol. 38 (2)
Donor-acceptor interaction-driven inclusion of carbanions by molecular cage induces large pKa shifts of conjugate carbon acids in water
- 17 July 2026
- Published by Elsevier in Chinese Chemical Letters
- Vol. 38 (2)
Donor-acceptor interaction-driven inclusion of carbanions by molecular cage induces large pKa shifts of conjugate carbon acids in water
- 7 January 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (2) , 1752-1765
Discovery of a Piperazine-Based Quaternary Ammonium Macrocycle as a Universal Reversal Agent for Heparin Anticoagulants
The development of a biocompatible antidote that can efficiently neutralize the anticoagulation activity of both unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs) represents an unmet medical need. Here, we report that a piperazine-derived tetracationic macrocycle can efficiently neutralize both UFH and LMWHs, including dalteparin, enoxaparin, and nadroparin. In vitro and in vivo assays reveal that the compound outperforms protamine, exhibiting significantly improved neutralization activity, a broad therapeutic window for all heparins, and high biocompatibility, which is confirmed by its very low coagulation and hemolysis effect, as well as a high therapeutic index (20.5), defined as the ratio of the maximum tolerated dose to the effective therapeutic dose. Molecular dynamics simulations indicate that binding may occur through interlocked threading and direct contact patterns, which are stabilized by intermolecular hydrogen bonding and ion-pair electrostatic attraction.
- 7 January 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (2) , 1752-1765
Discovery of a Piperazine-Based Quaternary Ammonium Macrocycle as a Universal Reversal Agent for Heparin Anticoagulants
The development of a biocompatible antidote that can efficiently neutralize the anticoagulation activity of both unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs) represents an unmet medical need. Here, we report that a piperazine-derived tetracationic macrocycle can efficiently neutralize both UFH and LMWHs, including dalteparin, enoxaparin, and nadroparin. In vitro and in vivo assays reveal that the compound outperforms protamine, exhibiting significantly improved neutralization activity, a broad therapeutic window for all heparins, and high biocompatibility, which is confirmed by its very low coagulation and hemolysis effect, as well as a high therapeutic index (20.5), defined as the ratio of the maximum tolerated dose to the effective therapeutic dose. Molecular dynamics simulations indicate that binding may occur through interlocked threading and direct contact patterns, which are stabilized by intermolecular hydrogen bonding and ion-pair electrostatic attraction.